GFAP reactivity, apolipoprotein E redistribution and cholesterol reduction in human astrocytes treated with α-synuclein
- 20 November 2009
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 469 (1), 11-14
- https://doi.org/10.1016/j.neulet.2009.11.034
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The role of apolipoprotein E in lipid metabolism in the central nervous systemCellular and Molecular Life Sciences, 2004
- CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregationHuman Molecular Genetics, 2004
- Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectorsTrends in Neurosciences, 2003
- Oxidative Modifications of α‐SynucleinAnnals of the New York Academy of Sciences, 2003
- Role of cholesterol in synapse formation and functionBiochimica et Biophysica Acta (BBA) - Biomembranes, 2003
- Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic miceProceedings of the National Academy of Sciences, 2002
- Role of glia-derived cholesterol in synaptogenesis: new revelations in the synapse–glia affairJournal of Physiology-Paris, 2002
- CNS Synaptogenesis Promoted by Glia-Derived CholesterolScience, 2001
- Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjectsNeuroscience Letters, 2000
- A Drosophila model of Parkinson's diseaseNature, 2000